Disease/Infection News

RSS

People with NCDs disproportionately impacted by the COVID-19 pandemic, report shows

Researchers at the Montreal Behavioural Medicine Centre (MBMC) say people with noncommunicable diseases (NCDs) such as heart disease, cancer, diabetes, or chronic lung ailments were disproportionately impacted by the COVID-19 pandemic.

9 Jan 2024

BCG vaccine's impact on innate immunity explained at cellular level

Bacillus Calmette-Guérin (BCG) is one of the world’s oldest and most widely used vaccines. It was developed in the early 20th century to provide protection from tuberculosis.

9 Jan 2024

New study sheds light on the biological properties of new COVID variant Pirola

Despite the end of the pandemic, COVID-19 continues to pose a serious health threat. Most individuals have established robust immune protection and do not develop severe disease but the infection can still lead to marked and sometimes long-lasting disease symptoms.

9 Jan 2024

Researchers unravel the workings of Group B Strep infections in pregnant women

Researchers from Binghamton University, State University of New York are unraveling the workings of Group B Strep (GBS) infections in pregnant women, which could someday lead to a vaccine.

9 Jan 2024

Real-world study tracks vaccine's power to protect kids from Delta and Omicron variants

Children and adolescents who received one of the main COVID-19 vaccines were significantly protected from the illness and showed no increased signs of cardiac complications compared to young people who were not vaccinated, according to a new real-world study led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Children's Hospital of Philadelphia (CHOP).

9 Jan 2024

How does religion impact vaccination coverage?

The effect of religious attitudes on real-world vaccination uptake.

9 Jan 2024

Infammasomes provide a therapeutic target against human diseases

The structure of inflammasomes and their role in diseases.

9 Jan 2024

Regular exercise key to unlocking whole-body health benefits and reducing disease risk

Study in Cell Metabolism explores how chronic exercise induces tissue adaptations, enhancing cardiometabolic health and reducing disease risk.

8 Jan 2024

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

Measuring airborne grass allergen levels instead of pollen counts will be more beneficial for hay fever sufferers as new research shows grass allergen levels are more consistently associated with hay fever symptoms than grass pollen counts.

8 Jan 2024

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

8 Jan 2024

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

A study led by UTHealth Houston reveals that T-cells specific for Epstein-Barr virus-infected cells are highly present in the cerebrospinal fluid of people with early-stage multiple sclerosis, suggesting a link between EBV and the disease.

8 Jan 2024

Long COVID's hidden toll: How does post-exertional malaise affect skeletal muscles?

Study investigates the pathophysiology of post-exertional malaise in long COVID patients, revealing skeletal muscle changes, exercise capacity reduction, metabolic disturbances, and tissue alterations.

8 Jan 2024

Three cytokine pairs found to be responsible for the body's damaging response to sepsis

Sepsis - when an infection causes the immune system to improperly target the body - is one of the leading causes of death in the ICU.

8 Jan 2024

Rising out-of-pocket costs for PrEP threaten key strategy in ending the HIV epidemic

Increasing patients' out of pocket costs for HIV pre-exposure prophylaxis (PrEP), medications, which have been shown to dramatically reduce the risk of HIV infection, could lead to a significant reduction in PrEP use and a rise in HIV infection rates, according to a new study co-led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins Bloomberg School of Public Health.

8 Jan 2024

Disease/Infection News

People with NCDs disproportionately impacted by the COVID-19 pandemic, report shows

BCG vaccine's impact on innate immunity explained at cellular level

New study sheds light on the biological properties of new COVID variant Pirola

Researchers unravel the workings of Group B Strep infections in pregnant women

Real-world study tracks vaccine's power to protect kids from Delta and Omicron variants

How does religion impact vaccination coverage?

Infammasomes provide a therapeutic target against human diseases

Regular exercise key to unlocking whole-body health benefits and reducing disease risk

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

Long COVID's hidden toll: How does post-exertional malaise affect skeletal muscles?

Three cytokine pairs found to be responsible for the body's damaging response to sepsis

Rising out-of-pocket costs for PrEP threaten key strategy in ending the HIV epidemic

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

Genetic keys to COVID-19 vaccine response unlocked

Inpatient costs of treating COVID-19 in the U.S.

Sesame protein-derived peptides show promise in fighting E. coli and S. aureus

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News